Insider to sell 26,250 SLDB shares on NASDAQ (NASDAQ: SLDB)

Rhea-AI Filing Summary

A holder of SLDB common stock, Paul Herzich, has filed a notice of intent to sell up to 26,250 shares through E*TRADE on the NASDAQ, with an aggregate market value of $168,968.63. The issuer had 82,561,235 shares outstanding and the approximate sale date is February 2, 2026.

The shares to be sold were acquired on February 2, 2026 via settlement of performance shares from the issuer as compensation. Over the prior three months, Herzich sold 2,701 shares of common stock on December 3, 2025, generating gross proceeds of $13,802.11.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 07:59 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE 500 RUTHERFORD AVENUE, THIRD FLOOR ALPHARETTA GA 30005	26250	168968.63	82561235	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/02/2026	Settlement of performance shares	Issuer			26250	02/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Herzich Paul 500 Rutherford Avenue CHARLESTOWN MA 02129	Common Stock	12/03/2025	2701	13802.11

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many SLDB shares is Paul Herzich planning to sell under this Form 144?

Paul Herzich filed to sell up to 26,250 shares of SLDB common stock. These shares have an aggregate market value of $168,968.63 and are planned for sale on or around February 2, 2026 through E*TRADE on the NASDAQ exchange.

How did Paul Herzich acquire the SLDB shares he plans to sell?

The 26,250 shares were acquired on February 2, 2026 through settlement of performance shares from the issuer as compensation. This means the stock was received as part of an incentive arrangement rather than purchased for cash in the open market.

What recent SLDB stock sales has Paul Herzich made before this planned transaction?

During the prior three months, Paul Herzich sold 2,701 shares of SLDB common stock on December 3, 2025, for $13,802.11 in gross proceeds. This earlier sale is disclosed alongside the new planned sale in the same Form 144 notice.

How large is this planned SLDB sale relative to shares outstanding?

The notice lists 82,561,235 shares outstanding for the issuer’s common stock. The planned sale of 26,250 shares is small compared with this baseline figure, indicating the transaction represents only a minor portion of total outstanding shares.

Through which broker and market will the SLDB shares be sold?

The planned sale will be executed through ETRADE FINANCIAL CORPORATION, with the shares to be sold on the NASDAQ exchange. The Form 144 lists E*TRADE’s address in Alpharetta, Georgia, and specifies NASDAQ as the trading venue for the common stock.

What representation does the seller make about inside information in this SLDB Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is a standard requirement associated with Form 144 sales.